Metastatic Castrate-Resistant Prostate Cancer CNTO888PCR2001

• Research type

  Research Study

• Full title

  An Open-label, Multicenter, Phase 2 Study of Single-agent CNTO 888 (an anti-CCL2 Monoclonal Antibody) for the Treatment of Subjects with Metastatic Castrate-Resistant Prostate Cancer

• IRAS ID

  24904

• Contact name

  Johann S de-Bono

• Eudract number

  2009-011251-48

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• Research summary

  N/A

• REC name

  London - Chelsea Research Ethics Committee

• REC reference

  09/H0801/70

• Date of REC Opinion

  28 Aug 2009

• REC opinion

  Favourable Opinion